- Home
- DSGX vs DVA Comparison
DSGX vs DVA Comparison
Compare DSGX & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGX
- DVA
- Stock Information
- Founded
- DSGX 1981
- DVA 1994
- Country
- DSGX Canada
- DVA United States
- Employees
- DSGX N/A
- DVA N/A
- Industry
- DSGX Computer Software: Prepackaged Software
- DVA Misc Health and Biotechnology Services
- Sector
- DSGX Technology
- DVA Health Care
- Exchange
- DSGX Nasdaq
- DVA Nasdaq
- Market Cap
- DSGX 9.0B
- DVA 9.4B
- IPO Year
- DSGX 1999
- DVA 1995
- Fundamental
- Price
- DSGX $93.90
- DVA $131.13
- Analyst Decision
- DSGX Buy
- DVA Hold
- Analyst Count
- DSGX 8
- DVA 3
- Target Price
- DSGX $122.75
- DVA $154.67
- AVG Volume (30 Days)
- DSGX 474.8K
- DVA 819.9K
- Earning Date
- DSGX 09-03-2025
- DVA 10-28-2025
- Dividend Yield
- DSGX N/A
- DVA N/A
- EPS Growth
- DSGX 14.17
- DVA 8.72
- EPS
- DSGX 1.69
- DVA 10.20
- Revenue
- DSGX $684,781,000.00
- DVA $13,161,328,000.00
- Revenue This Year
- DSGX $11.78
- DVA $5.96
- Revenue Next Year
- DSGX $13.45
- DVA $3.54
- P/E Ratio
- DSGX $54.45
- DVA $12.86
- Revenue Growth
- DSGX 12.69
- DVA 5.09
- 52 Week Low
- DSGX $91.00
- DVA $126.07
- 52 Week High
- DSGX $124.31
- DVA $179.60
- Technical
- Relative Strength Index (RSI)
- DSGX 37.32
- DVA 44.94
- Support Level
- DSGX $91.00
- DVA $129.20
- Resistance Level
- DSGX $104.44
- DVA $134.59
- Average True Range (ATR)
- DSGX 2.27
- DVA 2.67
- MACD
- DSGX -0.93
- DVA 0.26
- Stochastic Oscillator
- DSGX 21.58
- DVA 54.71
About DSGX Descartes Systems Group Inc. (The)
Descartes Systems Group provides a software solution that allows users in the shipping industry to communicate with one another. Its core product is the Global Logistics Network, which is best understood as transaction-driven. Descartes charges clients to send/receive messages, data, and documents on the GLN. Customers typically contract for a monthly minimum over a multiyear period. The GLN platform allows Descartes to upsell additional software modules as well, typically provided via a software-as-a-service model.
About DVA DaVita Inc.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.